These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1889178)

  • 1. Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum.
    Waites KB; Figarola TA; Schmid T; Crabb DM; Duffy LB; Simecka JW
    Diagn Microbiol Infect Dis; 1991; 14(3):265-71. PubMed ID: 1889178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agar dilution method for determination of antibiotic susceptibility of Ureaplasma urealyticum.
    Kenny GE; Cartwright FD; Roberts MC
    Pediatr Infect Dis; 1986; 5(6 Suppl):S332-4. PubMed ID: 2948164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.
    Robertson JA; Coppola JE; Heisler OR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):53-8. PubMed ID: 7283415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
    Rennie KA; Prasad ES; Wenman WM
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates.
    Waites KB; Crouse DT; Cassell GH
    Pediatr Infect Dis J; 1992 Jan; 11(1):23-9. PubMed ID: 1549404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.
    Kenny GE; Cartwright FD
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S215-8. PubMed ID: 8399919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
    Kanamoto Y; Miyake Y; Suginaka H; Usui T
    Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.
    Aydin D; Küçükbasmaci O; Gonullu N; Aktaş Z
    Chemotherapy; 2005 May; 51(2-3):89-92. PubMed ID: 15886468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F; Conventi L
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the E-Test for susceptibility testing of pneumococci.
    Jacobs MR; Bajaksouzian S; Appelbaum PC; Bolmström A
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):473-8. PubMed ID: 1643828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.
    Hillitt KL; Jenkins RE; Spiller OB; Beeton ML
    Lett Appl Microbiol; 2017 Mar; 64(3):198-202. PubMed ID: 27992658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
    Beeton ML; Chalker VJ; Maxwell NC; Kotecha S; Spiller OB
    Antimicrob Agents Chemother; 2009 May; 53(5):2020-7. PubMed ID: 19273669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Ureaplasma urealyticum.
    Davis JW; Hanna BA
    J Clin Microbiol; 1981 Feb; 13(2):320-5. PubMed ID: 7204548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.
    Govender S; Gqunta K; le Roux M; de Villiers B; Chalkley LJ
    J Antimicrob Chemother; 2012 Dec; 67(12):2821-4. PubMed ID: 22879459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women.
    Martínez MA; Ovalle A; Santa-Cruz A; Barrera B; Vidal R; Aguirre R
    Scand J Infect Dis; 2001; 33(8):604-10. PubMed ID: 11525356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.